<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1250"/><api:result><api:object category="publication" id="1250" last-affected-when="2024-03-17T08:20:21.783+00:00" last-modified-when="2024-03-17T08:20:21.783+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1250" created-when="2010-05-17T13:47:34.4+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-24</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1400150" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2265.2000.01072.x" last-modified-when="2023-10-07T00:10:29.923+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:sec&gt;&lt;jats:title&gt;OBJECTIVE&lt;/jats:title&gt;&lt;jats:p&gt;Thyroid‐associated ophthalmopathy is a progressive eye disorder affecting the extraocular muscle and orbital connective tissue and is considered to have an autoimmune aetiology. A recent study reported a close relationship between serum antibodies against the flavoprotein subunit of succinate dehyhdrogenase (SDHFp) and active thyroid‐associated ophthalmopathy involving eye muscle damage. The aim of the present study was to develop a sensitive and quantitative radiobinding assay for the detection of antibodies to the flavoprotein subunit of succinate dehydrogenase and to use this to determine the distribution of antibodies in different patient groups.&lt;/jats:p&gt;&lt;/jats:sec&gt;&lt;jats:sec&gt;&lt;jats:title&gt;DESIGN AND PATIENTS&lt;/jats:title&gt;&lt;jats:p&gt;Serum samples from the following patient groups were analysed: 20 systemic lupus erythematosus; 20 Addison's disease; 26 autoimmune hypothyroidism; 28 Graves' hyperthyroidism; 12 pretibial myxoedema; 25 thyroid‐associated ophthalmopathy. Sera from 20 healthy subjects were used as controls. [&lt;jats:sup&gt;35&lt;/jats:sup&gt;S]‐labelled succinate dehydrogenase flavoprotein was produced in an &lt;jats:italic&gt;in vitro&lt;/jats:italic&gt; transcription‐translation system and subsequently used in immunoprecipitation experiments with sera from patient and control groups to test for the presence of antibodies to the flavoprotein.&lt;/jats:p&gt;&lt;/jats:sec&gt;&lt;jats:sec&gt;&lt;jats:title&gt;RESULTS&lt;/jats:title&gt;&lt;jats:p&gt;Succinate dehydrogenase flavoprotein antibodies were detected in five of the 20 (25%) patients with Addison's disease, six of the 20 (30%) with systemic lupus erythematosus, five of the 26 (19%) with autoimmune hypothyroidsm, six of the 28 (21%) with Graves' hyperthyroidism, two of the 12 (17%) with pretibial myxoedema and three of the 25 (12%) with thyroid‐associated ophthalmopathy. The frequencies of flavoprotein antibodies were significantly greater than controls (&lt;jats:italic&gt;P&lt;/jats:italic&gt;‐value &amp;lt; 0.05) for patients with systemic lupus erythematosus (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.02), but not for patients with either Addison's disease (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.05), pretibial myxoedema (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.13), Graves' hyperthyroidism (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.07), autoimmune hypothyroidism (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.06) or thyroid‐associated ophthalmopathy (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.24). For the patients with thyroid‐associated ophthalmopathy, the frequency of SDHFp antibodies did not appear to be related to the length of time from diagnosis: the group containing samples taken less than one year from diagnosis showed no increased frequency of SDHFp antibodies when compared to controls (&lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.10), with three of the 18 (17%) patients being positive. With respect to seven patients with thyroid‐associated ophthalmopathy diagnosed for more than a year, SDHFp antibodies were not detected in any of their serum samples. In addition, the clinical severity of the disease, as recorded by the NOSPECS classification, did not correlate with the frequency of SDHFp antibodies: &lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.13, 0.33 and 0.38, respectively, for patients with Grade II, III and IV ophthalmopathy. Similar results were also found in the case of patients with pretibial myxoedema and eye disease: &lt;jats:italic&gt;P &lt;/jats:italic&gt;= 0.06 for patients with Grade III ophthalmopathy and, SDHFp antibodies were not detected in any of the sera taken from patients with Grade IV ophthalmopathy. In addition, no association was found between disease duration and the frequency of antibodies to the flavoprotein in this patient group.&lt;/jats:p&gt;&lt;/jats:sec&gt;&lt;jats:sec&gt;&lt;jats:title&gt;CONCLUSIONS&lt;/jats:title&gt;&lt;jats:p&gt;Our results indicate that succinate dehydrogenase flavoprotein antibodies are not a suitable marker for thyroid‐associated ophthalmopathy, at least with the assay system used, as they can be found in patients who do not have eye disease and therefore lack the disease specificity required of a diagnostic tool.&lt;/jats:p&gt;&lt;/jats:sec&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Smith</api:last-name><api:initials></api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials></api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials></api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2265.2000.01072.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2265.2000.01072.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2265.2000.01072.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2265</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical Endocrinology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>24</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2265.2000.01072.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>28</api:day><api:month>9</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="1319310" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033828546" last-modified-when="2021-06-29T13:17:51+01:00"><api:citation-count>4</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>OBJECTIVE: Thyroid-associated ophthalmopathy is a progressive eye disorder affecting the extraocular muscle and orbital connective tissue and is considered to have an autoimmune aetiology. A recent study reported a close relationship between serum anti-bodies against the flavoprotein subunit of succinate dehyhdrogenase (SDHFp) and active thyroid-associated ophthalmopathy involving eye muscle damage. The aim of the present study was to develop a sensitive and quantitative radiobinding assay for the detection of antibodies to the flavoprotein subunit of succinate dehydrogenase and to use this to determine the distribution of antibodies in different patient groups. DESIGN AND PATIENTS: Serum samples from the following patient groups were analysed: 20 systemic lupus erythematosus; 20 Addison's disease; 26 auto-immune hypothyroidism; 28 Graves' hyperthyroidism; 12 pretibial myxoedema; 25 thyroid-associated ophthalmopathy. Sera from 20 healthy subjects were used as controls. [35S]-labelled succinate dehydrogenase flavoprotein was produced in an in vitro transcription-translation system and subsequently used in immunoprecipitation experiments with sera from patient and control groups to test for the presence of antibodies to the flavoprotein. RESULTS: Succinate dehydrogenase flavoprotein antibodies were detected in five of the 20 (25%) patients with Addison's disease, six of the 20 (30%) with systemic lupus erythematosus, five of the 26 (19%) with autoimmune hypothyroidsm, six of the 28 (21%) with Graves' hyperthyroidism, two of the 12 (17%) with pretibial myxoedema and three of the 25 (12%) with thyroid-associated ophthalmopathy. The frequencies of flavoprotein antibodies were significantly greater than controls (P-value &lt;0.05) for patients with systemic lupus erythematosus (P=0.02), but not for patients with either Addison's disease (P=0.05), pretibial myxoedema (P=0.13), Graves' hyperthyroidism (P=0.07), autoimmune hypothyroidism (P=0.06) or thyroid-associated ophthalmopathy (P=0.24). For the patients with thyroid-associated ophthalmopathy, the frequency of SDHFp antibodies did not appear to be related to the length of time from diagnosis: The group containing samples taken less than one year from diagnosis showed no increased frequency of SDHFp antibodies when compared to controls (P=0.10), with three of the 18 (17%) patients being positive. With respect to seven patients with thyroid-associated ophthalmopathy diagnosed for more than a year, SDHFp antibodies were not detected in any of their serum samples. In addition, the clinical severity of the disease, as recorded by the NOSPECS classification, did not correlate with the frequency of SDHFp antibodies: P=0.13, 0.33 and 0.38, respectively, for patients with Grade II, III and IV ophthalmopathy. Similar results were also found in the case of patients with pretibial myxoedema and eye disease: P=0.06 for patients with Grade III ophthalmopathy and, SDHFp antibodies were not detected in any of the sera taken from patients with Grade IV ophthalmopathy. In addition, no association was found between disease duration and the frequency of antibodies to the flavoprotein in this patient group. CONCLUSIONS: Our results indicate that succinate dehydrogenase flavoprotein antibodies are not a suitable marker for thyroid-associated ophthalmopathy, at least with the assay system used, as they can be found in patients who do not have eye disease and therefore lack the disease specificity required of a diagnostic tool.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55665136000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">18438258900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Smith</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57197977992</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">18438747100</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">18438757400</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2265.2000.01072.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2265.2000.01072.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2265.2000.01072.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10971445</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical Endocrinology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>10</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: Analysis of specificity in autoimmune thyroid disease</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="1250" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10971445" last-modified-when="2020-04-29T06:07:16.3+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>OBJECTIVE: Thyroid-associated ophthalmopathy is a progressive eye disorder affecting the extraocular muscle and orbital connective tissue and is considered to have an autoimmune aetiology. A recent study reported a close relationship between serum antibodies against the flavoprotein subunit of succinate dehyhdrogenase (SDHFp) and active thyroid-associated ophthalmopathy involving eye muscle damage. The aim of the present study was to develop a sensitive and quantitative radiobinding assay for the detection of antibodies to the flavoprotein subunit of succinate dehydrogenase and to use this to determine the distribution of antibodies in different patient groups. DESIGN AND PATIENTS: Serum samples from the following patient groups were analysed: 20 systemic lupus erythematosus; 20 Addison's disease; 26 autoimmune hypothyroidism; 28 Graves' hyperthyroidism; 12 pretibial myxoedema; 25 thyroid-associated ophthalmopathy. Sera from 20 healthy subjects were used as controls. [35S]-labelled succinate dehydrogenase flavoprotein was produced in an in vitro transcription-translation system and subsequently used in immunoprecipitation experiments with sera from patient and control groups to test for the presence of antibodies to the flavoprotein. RESULTS: Succinate dehydrogenase flavoprotein antibodies were detected in five of the 20 (25%) patients with Addison's disease, six of the 20 (30%) with systemic lupus erythematosus, five of the 26 (19%) with autoimmune hypothyroidsm, six of the 28 (21%) with Graves' hyperthyroidism, two of the 12 (17%) with pretibial myxoedema and three of the 25 (12%) with thyroid-associated ophthalmopathy. The frequencies of flavoprotein antibodies were significantly greater than controls (P-value &lt; 0.05) for patients with systemic lupus erythematosus (P = 0.02), but not for patients with either Addison's disease (P = 0.05), pretibial myxoedema (P = 0.13), Graves' hyperthyroidism (P = 0.07), autoimmune hypothyroidism (P = 0.06) or thyroid-associated ophthalmopathy (P = 0.24). For the patients with thyroid-associated ophthalmopathy, the frequency of SDHFp antibodies did not appear to be related to the length of time from diagnosis: the group containing samples taken less than one year from diagnosis showed no increased frequency of SDHFp antibodies when compared to controls (P = 0.10), with three of the 18 (17%) patients being positive. With respect to seven patients with thyroid-associated ophthalmopathy diagnosed for more than a year, SDHFp antibodies were not detected in any of their serum samples. In addition, the clinical severity of the disease, as recorded by the NOSPECS classification, did not correlate with the frequency of SDHFp antibodies: P = 0.13, 0.33 and 0.38, respectively, for patients with Grade II, III and IV ophthalmopathy. Similar results were also found in the case of patients with pretibial myxoedema and eye disease: P = 0.06 for patients with Grade III ophthalmopathy and, SDHFp antibodies were not detected in any of the sera taken from patients with Grade IV ophthalmopathy. In addition, no association was found between disease duration and the frequency of antibodies to the flavoprotein in this patient group. CONCLUSIONS: Our results indicate that succinate dehydrogenase flavoprotein antibodies are not a suitable marker for thyroid-associated ophthalmopathy, at least with the assay system used, as they can be found in patients who do not have eye disease and therefore lack the disease specificity required of a diagnostic tool.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials>EH</api:initials><api:first-names>EH</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>H</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Clinical Sciences, Northern General Hospital, University of Sheffield, Sheffield, UK. e.h.kemp@sheffield.ac.uk</api:line></api:address></api:addresses><api:email-address>e.h.kemp@sheffield.ac.uk</api:email-address></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials>JN</api:initials><api:first-names>JN</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>KA</api:initials><api:first-names>KA</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials>PF</api:initials><api:first-names>PF</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials>AP</api:initials><api:first-names>AP</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10971445</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2265.2000.01072.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2265.2000.01072.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2265.2000.01072.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clin Endocrinol (Oxf)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Addison Disease</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Autoantibodies</api:keyword><api:keyword scheme="mesh">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh">Case-Control Studies</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Flavoproteins</api:keyword><api:keyword scheme="mesh">Graves Disease</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypothyroidism</api:keyword><api:keyword scheme="mesh">Leg Dermatoses</api:keyword><api:keyword scheme="mesh">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myxedema</api:keyword><api:keyword scheme="mesh">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh">Succinate Dehydrogenase</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>cen1072</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>10</api:day><api:month>10</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="882342" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10971445" last-modified-when="2023-09-12T18:38:49.397+01:00"><api:citation-count>3</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Objective&lt;/h4&gt;Thyroid-associated ophthalmopathy is a progressive eye disorder affecting the extraocular muscle and orbital connective tissue and is considered to have an autoimmune aetiology. A recent study reported a close relationship between serum antibodies against the flavoprotein subunit of succinate dehyhdrogenase (SDHFp) and active thyroid-associated ophthalmopathy involving eye muscle damage. The aim of the present study was to develop a sensitive and quantitative radiobinding assay for the detection of antibodies to the flavoprotein subunit of succinate dehydrogenase and to use this to determine the distribution of antibodies in different patient groups.&lt;h4&gt;Design and patients&lt;/h4&gt;Serum samples from the following patient groups were analysed: 20 systemic lupus erythematosus; 20 Addison's disease; 26 autoimmune hypothyroidism; 28 Graves' hyperthyroidism; 12 pretibial myxoedema; 25 thyroid-associated ophthalmopathy. Sera from 20 healthy subjects were used as controls. [35S]-labelled succinate dehydrogenase flavoprotein was produced in an in vitro transcription-translation system and subsequently used in immunoprecipitation experiments with sera from patient and control groups to test for the presence of antibodies to the flavoprotein.&lt;h4&gt;Results&lt;/h4&gt;Succinate dehydrogenase flavoprotein antibodies were detected in five of the 20 (25%) patients with Addison's disease, six of the 20 (30%) with systemic lupus erythematosus, five of the 26 (19%) with autoimmune hypothyroidsm, six of the 28 (21%) with Graves' hyperthyroidism, two of the 12 (17%) with pretibial myxoedema and three of the 25 (12%) with thyroid-associated ophthalmopathy. The frequencies of flavoprotein antibodies were significantly greater than controls (P-value &lt; 0.05) for patients with systemic lupus erythematosus (P = 0.02), but not for patients with either Addison's disease (P = 0.05), pretibial myxoedema (P = 0.13), Graves' hyperthyroidism (P = 0.07), autoimmune hypothyroidism (P = 0.06) or thyroid-associated ophthalmopathy (P = 0.24). For the patients with thyroid-associated ophthalmopathy, the frequency of SDHFp antibodies did not appear to be related to the length of time from diagnosis: the group containing samples taken less than one year from diagnosis showed no increased frequency of SDHFp antibodies when compared to controls (P = 0.10), with three of the 18 (17%) patients being positive. With respect to seven patients with thyroid-associated ophthalmopathy diagnosed for more than a year, SDHFp antibodies were not detected in any of their serum samples. In addition, the clinical severity of the disease, as recorded by the NOSPECS classification, did not correlate with the frequency of SDHFp antibodies: P = 0.13, 0.33 and 0.38, respectively, for patients with Grade II, III and IV ophthalmopathy. Similar results were also found in the case of patients with pretibial myxoedema and eye disease: P = 0.06 for patients with Grade III ophthalmopathy and, SDHFp antibodies were not detected in any of the sera taken from patients with Grade IV ophthalmopathy. In addition, no association was found between disease duration and the frequency of antibodies to the flavoprotein in this patient group.&lt;h4&gt;Conclusions&lt;/h4&gt;Our results indicate that succinate dehydrogenase flavoprotein antibodies are not a suitable marker for thyroid-associated ophthalmopathy, at least with the assay system used, as they can be found in patients who do not have eye disease and therefore lack the disease specificity required of a diagnostic tool.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Clinical Sciences, Northern General Hospital, University of Sheffield, Sheffield, UK. e.h.kemp@sheffield.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials>EH</api:initials><api:first-names>EH</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>H</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-0313-8916</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials>JN</api:initials><api:first-names>JN</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>KA</api:initials><api:first-names>KA</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials>PF</api:initials><api:first-names>PF</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials>AP</api:initials><api:first-names>AP</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2265.2000.01072.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2265.2000.01072.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2265.2000.01072.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2265</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10971445</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical endocrinology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh">Myxedema</api:keyword><api:keyword scheme="mesh">Leg Dermatoses</api:keyword><api:keyword scheme="mesh">Addison Disease</api:keyword><api:keyword scheme="mesh">Hypothyroidism</api:keyword><api:keyword scheme="mesh">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh">Succinate Dehydrogenase</api:keyword><api:keyword scheme="mesh">Flavoproteins</api:keyword><api:keyword scheme="mesh">Autoantibodies</api:keyword><api:keyword scheme="mesh">Case-Control Studies</api:keyword><api:keyword scheme="mesh">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Graves Disease</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>6</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="2911404" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1033350326" last-modified-when="2024-03-17T08:20:21.79+00:00"><api:citation-count>3</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01261423177.06</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Smith</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.011771130577.14</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0637506515.52</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2265.2000.01072.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2265.2000.01072.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2265.2000.01072.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10971445</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>0.49</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical Endocrinology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Lupus</api:keyword><api:keyword scheme="rcdc">Autoimmune Disease</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="hrcs-rac">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac">4.1 Discovery and preclinical testing of markers and technologies</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="mesh">Addison Disease</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Autoantibodies</api:keyword><api:keyword scheme="mesh">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh">Case-Control Studies</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Flavoproteins</api:keyword><api:keyword scheme="mesh">Graves Disease</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypothyroidism</api:keyword><api:keyword scheme="mesh">Leg Dermatoses</api:keyword><api:keyword scheme="mesh">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Myxedema</api:keyword><api:keyword scheme="mesh">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh">Succinate Dehydrogenase</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>24</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.12</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="242273" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000089591100004" last-modified-when="2024-03-14T06:00:24.253+00:00"><api:citation-count>3</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials>EH</api:initials><api:first-names>EH</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>H</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">D-1665-2011</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials>JN</api:initials><api:first-names>JN</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>KA</api:initials><api:first-names>KA</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials>PF</api:initials><api:first-names>PF</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials>AP</api:initials><api:first-names>AP</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000089591100004&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">359BF</api:identifier><api:identifier scheme="pubmed">10971445</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CLINICAL ENDOCRINOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" id="25557" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000089591100004" last-modified-when="2014-07-25T11:08:25.843+01:00"><api:citation-count>2</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1322"/></api:links><api:last-name>Kemp</api:last-name><api:initials>EH</api:initials><api:first-names>EH</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>H</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ridgway</api:last-name><api:initials>JN</api:initials><api:first-names>JN</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Smith</api:last-name><api:initials>KA</api:initials><api:first-names>KA</api:first-names><api:separate-first-names><api:first-name>K</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1247" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1247"/></api:links><api:last-name>Watson</api:last-name><api:initials>PF</api:initials><api:first-names>PF</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1250" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1250"/></api:links><api:last-name>Weetman</api:last-name><api:initials>AP</api:initials><api:first-names>AP</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0300-0664</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CLIN ENDOCRINOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>EYE MUSCLE</api:keyword><api:keyword>GRAVES HYPERTHYROIDISM</api:keyword><api:keyword>SERUM ANTIBODIES</api:keyword><api:keyword>ORBITAL TISSUE</api:keyword><api:keyword>OPHTHALMOPATHY</api:keyword><api:keyword>PROTEIN</api:keyword><api:keyword>PATHOGENESIS</api:keyword><api:keyword>FIBROBLAST</api:keyword><api:keyword>RECEPTOR</api:keyword><api:keyword>RADIOIMMUNOASSAY</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>291</api:begin-page><api:end-page>299</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Addison Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Autoantibodies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Case-Control Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Flavoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Graves Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hypothyroidism</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Leg Dermatoses</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Myxedema</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Succinate Dehydrogenase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Myxedema</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Leg Dermatoses</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Addison Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hypothyroidism</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Succinate Dehydrogenase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Flavoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Autoantibodies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Case-Control Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Graves Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Lupus</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Autoimmune Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4.1 Discovery and preclinical testing of markers and technologies</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Addison Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Autoantibodies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Autoimmune Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Case-Control Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Flavoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Graves Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hypothyroidism</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Leg Dermatoses</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lupus Erythematosus, Systemic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Myxedema</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Predictive Value of Tests</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Succinate Dehydrogenase</api:keyword><api:keyword origin="record-data" source="wos">EYE MUSCLE</api:keyword><api:keyword origin="record-data" source="wos">GRAVES HYPERTHYROIDISM</api:keyword><api:keyword origin="record-data" source="wos">SERUM ANTIBODIES</api:keyword><api:keyword origin="record-data" source="wos">ORBITAL TISSUE</api:keyword><api:keyword origin="record-data" source="wos">OPHTHALMOPATHY</api:keyword><api:keyword origin="record-data" source="wos">PROTEIN</api:keyword><api:keyword origin="record-data" source="wos">PATHOGENESIS</api:keyword><api:keyword origin="record-data" source="wos">FIBROBLAST</api:keyword><api:keyword origin="record-data" source="wos">RECEPTOR</api:keyword><api:keyword origin="record-data" source="wos">RADIOIMMUNOASSAY</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1114 Paediatrics and Reproductive Medicine</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Endocrinology &amp; Metabolism</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0300-0664" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973732" title="Clinical Endocrinology"><api:records><api:record source-name="summary"><api:title>Clinical Endocrinology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1250/relationships"/></api:object></api:result></api:response>